Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07459660

1 development in the corpus

NCT07459660

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 7, 2026 · PHASE 2 TRIAL

An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

ClinicalTrials.gov

This is a clinical trial registry record describing an ongoing Phase 2 open-label extension study with no results posted; no efficacy or safety data are yet available to evaluate.

PreliminaryML-007C-MA NCT07459660 Psychosis Associated With Alzheimer's Disease

Reported

Planned enrollment210

Study phasePhase 2

Study duration52 weeks

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support